Objectives: As part of a series of Patient-Centered Outcomes Research Institute-funded large-scale retrospective observational studies on bipolar disorder (BD) treatments and outcomes, we sought the input of patients with BD and their family members to develop research questions. We aimed to identify systemic root causes of patient-reported challenges with BD management in order to guide subsequent studies and initiatives.
mental health care. 4, 5 Many of these aspects have not been fully investigated since research priorities are traditionally based on factors such as disease burden, health costs, feasibility of approach and its novelty, interests of donors and advocacy groups, and experts' opinions, rather than on patients' perspectives and concerns. 6, 7 The gap between research objectives and the real needs expressed by patients is emphasized by many authors, 8, 9 and this bias has been identified as a major shortcoming of previous research. 10 The value of stakeholder engagement in research is now commonly recognized, and extensive analysis of its practical implementation, methodology and evaluation has been performed. 11, 12 Involvement of patients in research agendas is increasingly implemented on a legislative basis in developed countries, 13 making patients not just "passive beneficiaries" but active participants in planning, designing, and evaluating research, as well as dissemination of its results. Three major justifications underlie this approach: (i) unique experiential knowledge brought by patients and their caregivers can elevate the quality and practical relevance of performed research; (ii) shared involvement of patients as consumers, taxpayers, voters and citizens increases trust in research findings and the legitimacy of decision-making; and (iii) mutual learning between all stakeholders is conducive to a shared and more objective view of the disease phenomena. 14, 15 New initiatives have been launched in Europe, North America, and Australia 15, 16 stressing multi-stakeholder engagement in research, with mental health being the second leading sphere following oncology. A study addressing US patients' greatest BD treatment concerns showed that major unmet needs include treatment of depression, followed by treatment access, affordability, relapse prevention, and treatment of mania and hypomania. 18 Top issues in a DBSA survey on patient−provider relationships were lack of: communication, collaboration, and recovery-oriented treatment that instills hope. 4 A patientcentered Canadian study on quality of life found that BD patients consider social support as the most important factor, followed by mental health, financial status, vocation and independence.
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Despite the abovementioned impressive efforts to build and prioritize large lists of BD patient concerns, and the growing use of systems approaches in psychiatric practice and research, [19] [20] [21] we have not found published attempts to: (i) integrate patient concerns into a causal model, and (ii) involve patients in the model building. Systems thinking approaches illustrate that effects are often several steps removed from causes, and, because of interdependences, myriad "symptoms" can result from very few root causes which have the greatest leverage for system improvement once addressed. Thus, the objective of the study was to engage with our patient partners to understand the large "symptoms" in BD management, and to propose models that highlight root causes where limited resources can be deployed to achieve the highest impact.
| PATIENTS AND METHODS
This study was conducted under a PCORI-funded research project "Longitudinal comparative effectiveness of bipolar disorder therapies" (ClinicalTrials.gov identifier: NCT02893371)-a retrospective concerns revealed two core conflicts: for patients, whether or not to take pharmacotherapy, and for mental health services, the dilemma of care quality vs quantity. [24] [25] [26] This process allows concomitant analysis of many systems/organizational problems to identify the few common causes to most or all of the identified UDEs, where interventions will produce the greatest improvement in the symptoms.
Conclusions
The Theory of Constraints thinking process for system improvement follows several steps. 
| RESULTS
A total of 34 individuals participated in the focus groups; 24 of them had BD and 11 had a close family member with BD. The characteristics of the participants are shown in Table S1 . Consistent with BD heterogeneity and complexity, 12 participants also reported comorbid mental disorders, including obsessive-compulsive disorder, major depressive disorder, social phobia, post-traumatic stress disorder, adjustment disorder, schizoaffective disorder, alcohol and substances abuse, epilepsy and Tourette's syndrome.
A total of 369 questions and statements resulted from the affinity mapping exercise, which were grouped into 33 categories across the three focus groups (Table S2 ). The top-ranked categories were
Medications in the Montana focus group, Education in the New Mexico group and Doctor communication/collaboration in the California group.
The second most highly ranked categories were represented by Other Treatments, Diagnosis and research and Holistic options, respectively.
Given that many of the 33 categories had overlapping content and similar names, they were subsequently grouped by researchers into 10 broader "themes", which were ranked by summing the constituent patient category scores. The top three themes were Alternatives and adjuncts to pharmacotherapy, Pharmacotherapy and Provider relations (Table 1) . We found that 176 out of the 312 items with interrogative content (56%) were at least partly answerable with the available data, all of which were categorized into one of the 10 newly defined broad themes.
The top 10 jointly rated questions/interrogative statements were placed in the following order by descending average score: "What can be done to eliminate suicidal thoughts with some medications?" (4.8),
"What are the risks of taking medications or not?" (4.7), "Medications: 
Social bias and stigma Q: "I would have asked for more education for all family members including siblings (under 18)."
Q: "I would have asked for more education for all family members including siblings (under 18)." comparison of individual drugs; the unique questions stressed by researcher stakeholders were related to BD treatment efficacy in general, BD "dangers", interaction of BD drugs with psychoactive substances, and pharmacotherapy in children (see Table S3 ).
Questions that scored the highest within each of the 10 broad themes are provided in Table 1 (separately for patient It causes many patients to oscillate between adherence and nonadherence to prescribed treatment. Discontinuous use of medications is known to increase the risk of drug resistance, which might worsen disease outcomes. 27 The third mode is to seek alternative F I G U R E 2 Treatment leads to wellness. A future reality tree (FRT) reflecting potential improvements in bipolar disorder (BD) care management is shown. Positive changes are framed in green rounded rectangles, additional entities in black rounded rectangles, and system interventions in square rectangles. Arrows signify direct causal relationships; arrows directed to "AND" operators imply that the combination of causes is needed to produce the resulting effect [Colour figure can be viewed at wileyonlinelibrary.com] F I G U R E 3 Quality vs quantity. A communication current reality tree (CCRT) reflecting causal relationships underlying patients' experience that mental health care does not address their needs is shown. Undesirable effects (UDEs) are framed in red rounded rectangles, and additional entities in black rounded rectangles. Arrows signify direct causal relationships; arrows directed to "AND" operators imply that the combination of causes is needed to produce the resulting effect. The lightning sign reflects a conflict between mutually exclusive alternatives. The UDEs at the top of the tree are the same as in Figure 1 , but represented in shortened form [Colour figure can be viewed at wileyonlinelibrary.com] F I G U R E 4 System overhaul. A future reality tree reflecting potential interventions to produce bipolar disorder (BD) management success is shown. Positive changes are framed in green rounded rectangles, additional entities in black rounded rectangles, and system interventions in square rectangles. Interventions shown in italics are being developed but are not yet ready for practical implementation. Arrows signify direct causal relationships; arrows directed to "AND" operators imply that the combination of causes is needed to produce the resulting effect. ECHO, Extension for Community Healthcare Outcomes [Colour figure can be viewed at wileyonlinelibrary.com] nonmedicamentous remedies, many of which have limited efficacy in alleviating BD symptoms, resulting in the loss of pharmacotherapy benefits and retaining the negatives associated with BD. 28 Given that, from our patients' perspective, mental health care often does not meet their needs, choosing pharmacotherapy can lead to additional negative consequences, including the UDEs of both medications and BD without the advantages from either. A negative experience with medication could reinforce a patient's belief that pharmacotherapy will be detrimental, which fosters the medication-free behavioral strategies.
On the other hand, BD untreated or treated with ineffective drugs tends to progress, which motivates patients to seek pharmacotherapy, but makes the disorder harder to treat. psychiatric care would lead patients to be more likely to continue to seek professional help in order to gain the benefits of pharmacotherapy and avoid the negative consequences of BD. However, some patients will still be inclined to keep the benefits of BD and try to seek alternative treatments. With better evidence on the alternative strategies, more efficacious ones could be employed, either alone or adjunctively with pharmacotherapy. As a result, more patients will gain the benefits of pharmacotherapy than will experience its undesirable effects, and the adverse consequences of being untreated will be reduced or eliminated. Even without a guaranteed adequate response to treatment, optimal management of BD would promote patient wellbeing and diminish the risk of complications or drug resistance, improving outcomes. An increased rate of favorable outcomes leads to a positive reinforcement of perceptions that pharmacotherapy is worthwhile, leading to a virtuous cycle of improved health for BD patients.
Causes for the cluster of UDEs "Mental health care does not address many patients' needs" in Figure 1 were elucidated in a second CCRT ( Figure 3) . The model in Figure 3 shows how resource limitations give rise to a conflict for providers over the quality vs quantity of mental health care. 29 Mutually exclusive standards of service related to physician visit time lead to two major negative outcomes:
the disadvantages of minimized contact with a specialist and lack of specialist access. This conflict, as well as a cluster of factors related to shortcomings of the current state of psychiatry, contribute to both the detrimental outcomes and lack of benefits reported by patients, as detailed in Figure 1 . Uncontrolled BD symptoms result in increased demand from the mentally ill population for mental health services, system overload and further reinforcement of the efficiency-focused strategy to cope with the increased consumption of services.
A need for systemic reformation of mental health care services was explicitly stated by the focus group participants during closing discussions. Focus group participants indicated difficulties with lack of comprehensiveness of care, and the need for a coordinated approach to address the problems identified. When the CCRT (Figure 3 ) was transformed into the FRT (Figure 4 ), interventions were proposed to improve the overall performance of mental health care for individuals with BD and their families. These included multi-level solutions ranging from biomarker development to reforms in education, standardization of diagnostic and treatment algorithms, and implementation of continuous improvement processes to achieve operational excellence.
| DISCUSSION
The major contribution of this paper is the proposal of causal models that integrate patient-driven research priorities into a comprehensive framework for focused intervention. While it is useful, for example, to discover that a top priority for focus group participants is alternative nonmedicamentous treatments, a deeper understanding that this effect may be explained by a core conflict over seeking vs avoiding pharmaco- Australian study on patients with depression and BD, which identified medication as the most important topic for research.
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Patients' concerns related to "Provider relations", "Understanding BD", "Support", "Diagnosis" and "Social bias and stigma" can be traced to a common cause of the provider's focus on care quantity (Figure 3) , where short visit times compromise comprehensive examination, patient and family psychoeducation, psychological support and appropriate referrals. Unproductive dialog with physicians drives patient inquiries about finding an appropriate provider, which represents a major concern under the "Health care navigation" theme.
In order to improve BD management, it is important not only to high energy levels and high productivity, compounded by a lack of insight that these "benefits" are symptoms of disease. 31 This rationale behind medication nonadherence is often unrecognized, and patient noncompliance is commonly attributed to ignorance, lack of insight and motivation, negative memories bias, or focus on shortterm needs. 32, 33 We suggest that this particular aspect of decisionmaking should become an important target of education for patients with BD and their families. However, additional research is needed to elucidate its role in BD outcomes, and additional psychosocial interventions should be developed in order to alleviate the loss of the perceived positives of BD.
Many of the proposed interventions to improve mental health care identified in Figure 4 already exist, but from our patients' experience are not implemented comprehensively. of the broad themes.
In terms of representativeness, two of the three focus groups were based in rural locations which may be more affected by phy- Despite the small number of participants in our study, one principle of the Theory of Constraints is that deep root causes underlying studied phenomena tend to be universal, suggesting that the core conflicts revealed in our study can be extrapolated to a larger population of patients with BD. As our next initiative, we intend to communicate with more BD patients about the conflicts revealed, and explore their insights and expectations with regard to the challenges elucidated by our models on their BD management "journey", in contrast with the expectations that were set by providers and by mental health brochures provided for BD patients.
| CONCLUSIONS
1. In our study, the highest priority for BD patients is better evidence on individualized pharmacotherapy and its alternatives, with emphasis on management of suicidal thoughts and manic states.
2.
The challenges in BD management appear to be driven by two interacting systemic core conflicts: for the patient, seeking vs avoiding pharmacotherapy; for the provider, quantity vs quality of care.
3.
The conflicts underlying patient decision-making should be investigated as a target for psychoeducational interventions, with particular emphasis on mitigating the loss of BD positives.
Implementation of advanced operational excellence approaches
for health system improvement should be more fully investigated in the domain of mental health care, with an emphasis on maximizing the benefits to patients with limited visit time and resources.
5. BD management requires a "system overhaul" that supports patients in: accessing mental health services, obtaining sufficient provider visit time, having their condition diagnosed early and accurately by means of objective tools, and receiving personalized multidisciplinary care including psychosocial support.
